Virtual Brain Platform for Epileptogenic Zone Simulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying and modulating the epileptogenic zone in the brain of epileptic patients are limited by their stationary nature and lack of effective diagnostic tools, particularly in non-stationary processes such as seizure recruitment in epilepsy.

Innovation Solution

A method involving a virtual brain platform that models epileptogenic and propagation zones using mathematical models and acquired brain data, allowing for the simulation of network modulations to mimic clinical interventions and identify optimal therapeutic strategies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If stationary connectivity based metrics are used to model brain networks, then model validation is simplified, but the model cannot capture non-stationary processes such as seizure recruitment and resting state dynamics

Engineering Contradiction:
Improveability to model non-stationary processesVSAvoidmodel complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements dynamic connectivity metrics that evolve over time, replacing static connectivity measures. The model incorporates time-varying parameters that adapt to capture non-stationary brain states including seizure recruitment dynamics and resting state fluctuations, enabling the system to model transient neurological conditions while maintaining computational tractability through efficient temporal sampling strategies

Inventive Principle:
Principle #15Dynamics

2Reliability

If comprehensive diagnostic testing and personalized treatment planning are implemented, then treatment effectiveness is improved, but time and resource consumption increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoiddiagnostic and treatment planning time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent performs preliminary virtual simulations of various surgical interventions and treatment strategies on patient-specific brain models before actual clinical procedures. By pre-testing multiple treatment scenarios in silico, the system identifies optimal treatment approaches in advance, reducing the need for extensive trial-and-error in the clinic and accelerating the personalized treatment planning process while maintaining high treatment effectiveness

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If the epileptogenic zone is precisely identified and modulated, then surgical outcomes are improved, but the complexity of identification and intervention planning increases

Engineering Contradiction:
Improveepileptogenic zone identification accuracyVSAvoididentification system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent creates a virtual copy of the patient's brain network model that replicates the structural and functional connectivity of the actual brain. This digital twin allows for non-invasive simulation of seizure propagation patterns and virtual surgical interventions, enabling precise epileptogenic zone identification through computational analysis without requiring complex invasive procedures or interpretation of complex clinical data by physicians

Inventive Principle:
Principle #26Copying

Data Source

PatentUS12232883B2Method of modulating epileptogenicity in a patient's brain
Publication Date: 2025.02.25 UNIV DAIX MARSEILLE
  • US12232883B2 patent drawing
  • US12232883B2 patent drawing
  • US12232883B2 patent drawing

AI summary

The method of modulating epileptogenicity in a brain of an epileptic patient includes: providing a virtual brain; providing a model of an epileptogenic and of a propagation zones and loading the models in the virtual brain to create a virtual epileptic brain; acquiring data of the brain of the epileptic patient; identifying, in the data, a location of at least one possible epileptogenic zone; fitting the virtual epileptic brain against the data acquired from the epileptic patient and parametrizing the at least one possible epileptogenic zone in the virtual epileptic brain as an epileptogenic zone; and simulating, within the virtual epileptic brain, the effect of a network modulation mimicking a clinical intervention of the brain of the patient.